Spectranetics to Hold 2014 Second Quarter Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Spectranetics to Hold 2014 Second Quarter Financial Results Conference Call on July 24

COLORADO SPRINGS, Colo., July 7, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq: SPNC ) today announced that the Company will release 2014 second quarter financial results after market close on Thursday, July 24, 2014. Company management will host an investment-community conference call beginning at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on Thursday, July 24 to discuss those results and to answer questions.

Individuals interested in listening to the conference call may do so by dialing (877) 561-2747 for domestic callers, or (973) 409-9689 for international callers, or from the webcast on the investor relations section of the Company's Web site at: www.spectranetics.com .  The webcast will be available on the Company's Web site for 14 days following the completion of the call.

About Spectranetics

Spectranetics develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are sold in over 40 countries and are used to treat arterial blockages in the heart and legs, and the removal of pacemaker and defibrillator leads.

The Company's Vascular Intervention (VI) products include a range of laser catheters for ablation of blockages in arteries above and below the knee. The Company also markets support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions. The Company markets aspiration and cardiac laser catheters to treat blockages in the heart.

The Lead Management (LM) product line includes excimer laser sheaths, dilator sheaths, mechanical sheaths and accessories for the removal of pacemaker and defibrillator cardiac leads.

COMPANY CONTACTS: Spectranetics Corporation Guy Childs, Chief Financial Officer (719) 633-8333 INVESTOR CONTACTS: Westwicke Partners, LLC Lynn Pieper (415) 202-5678

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 328

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 233

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 492

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 487

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 236

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 378

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 366

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 445

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 409

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

JSA Welcomes New Advisory Board Members in AI and Sustainability

Updated Category News Views 114

Expanding the Advisory Board at JSA JSA, a leading marketing agency dedicated to the digital infrastructure sector, has announced significant additions to its Advisory Board, welcoming two highly esteemed professionals, Bill Kleyman and Melissa Farney. These new members bring extensive expertise in sustainability and artificial intelligence, enhancing JSA's ability to...

Continue Reading
Eurobank's Successful EUR 600 Million Bond Sale Announcement

Updated Category News Views 175

Eurobank Achieves Milestone with EUR 600 Million Bond Sale Eurobank SA has recently marked a significant achievement by successfully selling EUR 600 million in callable senior preferred securities. This success is underlined by the absence of stabilisation actions, indicating a robust market demand for this financial instrument. Details of the Bond Offering According to...

Continue Reading
KBR Takes Charge of Major Fertilizer Project in Angola

Updated Category News Views 207

KBR Takes Charge of Major Fertilizer Project KBR (NYSE: KBR) has recently embarked on a significant venture by securing a contract for Project Management Consultancy (PMC) services that will support the development of a crucial fertilizer plant. This project, commissioned by AMUFERT, is pivotal in enhancing fertilizer production capacity. About the Fertilizer Project The...

Continue Reading
Revitalizing Lawn Care with Sunseeker's Elite X9 Series

Updated Category News Views 181

Revolutionizing Lawn Maintenance with Elite Technology At the forefront of innovation, Sunseeker is making headlines with its newest breakthrough, the Sunseeker Elite X9 Series. Advanced Mowing Capabilities Positioned to transform the landscaping industry, the Elite X9 Series robotic mowers operate effectively in demanding commercial environments. With the capacity to...

Continue Reading
Dr. Rajan Bhatt Takes Charge as New CEO of OrthoArizona

Updated Category News Views 1074

Dr. Rajan Bhatt Appointed as CEO of OrthoArizona OrthoArizona, recognized as one of the largest privately held orthopedic organizations in the nation, has recently named Dr. Rajan Bhatt as their new Chief Executive Officer. Dr. Bhatt is not only a renowned physician but also an entrepreneur with extensive business expertise, making him an ideal candidate for orchestrating...

Continue Reading